The board may refuse to issue or renew a license, permit, or certificate to, or may suspend, temporarily suspend, revoke, fine, place on probation, reprimand, reasonably restrict, or take any combination of these actions against any licensee, permit holder, or certificate holder for the following reasons:
(k). Failure to notify the board within fourteen (14) days of a change in one's home address.
According to DC Pharmacy Law, a health care facility may dispose of any pharmaceutical product, used or unused, by flushing the product down a drain.
True or False
According to DC Pharmacy Law, a health care facility may dispose of any pharmaceutical product, used or unused, by flushing the product down a drain.
Answer: False, [DC Official Code Title 22B Chapter 5 Section 500.1 and 500.2 ].
Effective July 1, 2013, unless authorized by this chapter, a health care facility that is determined to have disposed of a pharmaceutical product by flushing the product down a drain or by any other method that utilizes the public sewer system, shall be:
(a). Subject to a civil fine of up to one thousand dollars ($1,000) per occurrence; and
(b). Required to submit to the Board of Pharmacy, or its designee, a mitigation plan designed to prevent further such occurrences within thirty (30) days of receipt of a request for the mitigation plan.
At the time the pharmacist manager in whose name the registration was obtained ceases to be employed as the pharmacist manager, he or she shall report to the board within 30 days the fact that he or she is no longer manager of the prescription drug outlet.
True or False
At the time the pharmacist manager in whose name the registration was obtained ceases to be employed as the pharmacist manager, he or she shall report to the board within 30 days the fact that he or she is no longer manager of the prescription drug outlet.
(1). (a). A prescription drug outlet must be under the direct charge of a pharmacist manager. A proprietor who is not a pharmacist shall comply with this requirement and shall provide a manager who is a pharmacist.
(b). The registration of any prescription drug outlet becomes void if the pharmacist manager in whose name the prescription drug outlet registration was issued ceases to be engaged as the manager. The owner shall close the prescription drug outlet unless the owner:
(I). Employs a new pharmacist manager; and
(II). Within thirty days after termination of the former manager's employment:
(A). Applies to transfer the registration to the new pharmacist manager; and
(B). Pays the registration transfer fee.
(c). At the time the pharmacist manager in whose name the registration was obtained ceases to be employed as the pharmacist manager, he or she shall IMMEDIATELY (Not within 30 days) report to the board the fact that he or she is no longer manager of the prescription drug outlet.
The pharmacist manager is responsible as the manager until the cessation of employment is reported. The proprietor of the prescription drug outlet shall also notify the board of the termination of managership.
A patient comes to your pharmacy and presents the following prescription. The prescription reads:
Metoprolol 50 mg
1 tab po b.i.d. qty: 120
Refill: 3 times
Which of the following is TRUE?
a. Shall not fill more than 60 tablets.
b. Shall fill 120 tablets as indicated.
c. Shall not fill more than 360 tablets in a single filling.
d. Shall only fill 30 tablets.
Answer:
A patient comes to your pharmacy and presents the following prescription. The prescription reads:
Metoprolol 50 mg
1 tab po b.i.d. qty: 120
Refill: 3 times
Which of the following is TRUE?
a. Shall not fill more than 60 tablets.
b. Shall fill 120 tablets as indicated.
c. Shall not fill more than 360 tablets in a single filling.
d. Shall only fill 30 tablets.
Answer: Shall not fill more than 60 tablets, [California Pharmacy Law Chapter 4000 Section 4064.5].
A pharmacist may dispense not more than a 90-day supply of a dangerous drug other than a controlled substance pursuant to a valid prescription that specifies an initial quantity of less than a 90-day supply followed by periodic refills of that amount if all of the following requirements are satisfied:
(1). The patient has completed an initial 30-day supply of the dangerous drug.
(2). The total quantity of dosage units dispensed does not exceed the total quantity of dosage units authorized by the prescriber on the prescription, including refills.
(3). The prescriber has not specified on the prescription that dispensing the prescription in an initial amount followed by periodic refills is medically necessary.
(4). The pharmacist is exercising his or her professional judgment.
(b). For purposes of this section, if the prescription continues the same medication as previously dispensed in a 90-day supply, the initial 30-day supply under paragraph (1) of subdivision (a) is not required.
(c). A pharmacist dispensing an increased supply of a dangerous drug pursuant to this section shall notify the prescriber of the increase in the quantity of dosage units dispensed.
Mr. Smith comes to the pharmacy and asks for the prescription drug Hydrochlorothiazide. Upon reviewing his profile, the pharmacist has found that the patient has no refills left on the current prescription. The pharmacist calls the prescriber but he is out of town for 3 days. The pharmacist gives 3 days worth of medication to Mr. Smith. Is the pharmacist acting in accordance with the standard of care?
Answer: Yes or No
Mr. Smith comes to the pharmacy and asks for the prescription drug Hydrochlorothiazide. Upon reviewing his profile, the pharmacist has found that the patient has no refills left on the current prescription. The pharmacist calls the prescriber but he is out of town for 3 days. The pharmacist gives 3 days worth of medication to Mr. Smith. Is the pharmacist acting in accordance with the standard of care?
Answer: Yes, [California Pharmacy Law Chapter 4000 Section 4064].
Hydrochlorothiazide is considered a maintenance drug. It is normally indicated for the treatment of blood pressure. Mr. Smith has been taking this drug to control his blood pressure.
The pharmacist tried to contact the physician to find the current status of therapy. The pharmacist made a reasonable effort to prevent any health consequences that may arise due to discontinuation of therapy. The pharmacist was in accordance with the standard of care.
Emergency Refill of Prescription without Prescriber Authorization:
(a). A prescription for a dangerous drug or dangerous device may be refilled without the prescriber's authorization if the prescriber is unavailable to authorize the refill and if, in the pharmacist's professional judgment, failure to refill the prescription might interrupt the patient's ongoing care and have a significant adverse effect on the patient's well-being.
(b). The pharmacist shall inform the patient that the prescription was refilled pursuant to this section.
(c). The pharmacist shall inform the prescriber within a reasonable period of time of any refills dispensed pursuant to this section.
(d). Prior to refilling a prescription pursuant to this section, the pharmacist shall make every reasonable effort to contact the prescriber. The pharmacist shall make an appropriate record, including the basis for proceeding under this section.
(e). The prescriber shall not incur any liability as the result of a refilling of a prescription pursuant to this section.
(f). Notwithstanding Section 4060 or any other law, a person may possess a dangerous drug or dangerous device furnished without prescription pursuant to this section.
A patient brings a new prescription that is electronically generated and contains an electronic signature of prescriber. What shall pharmacist do?
a. Fill the prescription. b. Shall not fill the prescription.
Answer:
A patient brings a new prescription that is electronically generated and contains an electronic signature of prescriber. What shall pharmacist do?
a. Fill the prescription. b. Shall not fill the prescription.
Answer: Shall not fill the prescription, [New York State Laws and Regulations Article 137, Section 6810 and http://www.op.nysed.gov/prof/pharm/pharmelectrans.htm question 5].
Once a prescription is handed to the patient it is no longer an electronic prescription and must contain the handwritten, pen-to-paper signature of the prescriber.
If a paper copy prescription that is generated by the pharmacist or pharmacy technician from the electronic prescription system is printed, a manual signature of prescribing practitioner shall be obtained within 72 hours.
True or False
If a paper copy prescription that is generated by the pharmacist or pharmacy technician from the electronic prescription system is printed, a manual signature of prescribing practitioner shall be obtained within 72 hours.
If a paper copy prescription that is generated by the pharmacist or pharmacy technician from the electronic prescription system is printed, an electronic signature may be substituted for a manual signature.
If the drug was prescribed by generic name, which of the following shall be noted on the face of a prescription?
I. The name of the manufacturer or distributor. II. The national drug code number. III. The trade name.
a. I only b. II only c. III only d. I or II or III only
Answer:
If the drug was prescribed by generic name, which of the following shall be noted on the face of a prescription?
I. The name of the manufacturer or distributor. II. The national drug code number. III. The trade name.
a. I only b. II only c. III only d. I or II or III only
Answer: I or II or III only, [Title 12 Alaska Administrative Code (AAC) Section 52.460(b)(5)].
If the drug was prescribed by generic name or if an equivalent drug product other than the one prescribed was dispensed, for the drug product actually dispensed, at least ONE of the following shall be noted on the face of a prescription:
(A). the name of the manufacturer or distributor; (B). the national drug code number; (C). the short name code; (D). the trade name.
Products that are not commercially available may be compounded for hospital or office use but shall not be resold or dispensed.
Nonprescription items may be compounded upon order by a practitioner for sale as long as the labeling complies with RSA 318:47-a and the product is not a copy of, or similar to, prescription or nonprescription products.
According to Washington State Pharmacy Law, a preceptor may designate a licensed pharmacist to supervise the intern during the preceptor’s absence from the site; however the hours of experience gained while the certified preceptor is absent from the site shall not be counted toward fulfilling any internship requirement.
Answer: True or False
According to Washington State Pharmacy Law, a preceptor may designate a licensed pharmacist to supervise the intern during the preceptor’s absence from the site; however the hours of experience gained while the certified preceptor is absent from the site shall not be counted toward fulfilling any internship requirement.
According to Washington State Pharmacy Law, a preceptor may designate a licensed pharmacist to supervise the intern during the preceptor's absence from the site; however the hours of experience gained while the certified preceptor is absent from the site shall not be counted toward fulfilling any internship requirement.
The intern shall send notification to the board of pharmacy on or before the intern's first day of training.
Such notification shall consist of the date, the name of the pharmacy, and the name of the preceptor where the intern expects to begin his/her internship.
The board of pharmacy shall promptly notify the intern of the acceptability of the preceptor under whom the intern expects to gain experience. Internship credit will not be accepted until the preceptor has been certified.
